Sponsor
The Leukemia and Lymphoma Society of Canada
Description
Each year, The Leukemia & Lymphoma Society of Canada forms a new group of medical experts with the task of reviewing research projects taking place in Canada that show the greatest promise in advancing our understanding of different blood cancers, ability to test therapies and ultimately, to find cures.
Operating Grants: Our Operating Grants offer funding to basic research that contribute to the advancement of science aimed at preventing, detecting and treating blood cancers.
New Idea Award: The New Idea Award is a concept award to support innovative approaches that may fundamentally change the understanding, diagnosis and/or treatment of blood cancers and related pre-malignant conditions.
This grant program is designed to identify novel research strategies with a potential for high impact on blood cancer. Specifically, this program supports the initial exploration of untested but potentially transformative ideas that challenge our knowledge of blood cancer or the manner in which we approach diagnosis or treatment. Competitive proposals will describe ideas that take the investigator’s research in a substantially new direction, and thus preliminary data is not required.
In order to receive such an award, applicants must succinctly describe as one aim the innovative idea/approach and a method for testing it within the one year grant period.
Eligibility
Operating Grants: Applicant must have a faculty appointment at a Canadian university. New investigators as well as established ones are encouraged to submit applications.
New Idea Award: Investigators in academic laboratories are eligible to apply. Researchers in any field are encouraged to apply, but the proposal must directly address blood cancer. Investigators must demonstrate that their research environment is equipped and suitable for the proposed study; this includes demonstrated access to patient materials, where applicable.
Collaboration between multiple investigators to strengthen the proposed research will be considered favourably, but is not a requirement. Applicants must have a faculty appointment at a Canadian university to qualify for funding.
Applicants should hold a Ph.D., M.D., D.V.M. or equivalent degree.
Maximum Project Value
Operating Grants: maximum $100,000 per year
New Idea Award: up to $75,000
Indirect Costs
0%
Project Duration
Operating Grants: 2 year
New Idea Award: 1 year
Special Notes
Leukemia and Lymphoma Society of Canada - Operating Grants and New Idea Award
Deadlines
If College-level review is required, your College will communicate its earlier internal deadlines.
| Type | Date | Notes |
|---|---|---|
External Deadline | Letter of Intent - Mandatory for both Operating Grants and New Idea Award: PI to Submit a Letter of Intent directly to sponsor. | |
Internal Deadline | Application - Operating Grants and New Idea Award: PI to submit a copy of complete application along with a signed OR5 form to: research.services@uoguelph.ca | |
External Deadline | Application - Operating Grants and New Idea Award: PI to submit on-line application. Operating Grants application must be: New Idea Award: The project description should be 3 pages or less (including figures, excluding references). Application templates are found on our grants management website: https://proposalcentral.altum.com/ |
Information For Co-applicants
If you need to meet a deadline set by the lead institution for this opportunity, please ensure that you provide the Office of Research with at least five days in advance of the lead institution’s deadline to review the application, or your proposed component of the project. Please be in touch with the Office of Research (contact information below) ahead of the deadline if it looks like it will be difficult for you to submit all the required documentation on time (i.e. budget, proposal, OR-5 Form).
Attachment(s)
| Attachment | Size |
|---|---|
 Operating Grants Guidelines | 96.82 KB |
| New Idea Award Guidelines | 96.11 KB |